Human Papillomavirus Vaccine: A New Opportunity for The Treatment of Human Papillomavirus Infections

Authors

  • Sneha Ambwani Dr. S.N. Medical College, Jodhpur
  • Prabhu Prakash Dr. S.N. Medical College, Jodhpur
  • Seema Surana Dr. S.N. Medical College, Jodhpur
  • Suman Bhansali Dr. S.N. Medical College, Jodhpur

Keywords:

PAPILLOMAVIRUS, VACCINE, INFECTIONS

Abstract

NA

References

Gunter J.Genital and perianal warts:New treatment opportuni-ties for human papillomavirus infection.Am J Obstet Gynecol 2003; 18:S3-S11.

Kennedy CM and Boardman LA.New approaches to external genital warts and vulvular intraepithelial neoplasia.Cli Obstet. Gynecol 2008;51(3): 518-526.

Centre for Disease control and Prevention. Sexually Transmitted Disease Treatment Guidelines MMWR 2006;55(NO RR 11): 1-94.

Maw R.Critical appraisal of commonly used treatment for geni-tal warts.Int J STD AIDS 2004; 15:357-364.

Ault KA.Human Papillomavirus Vaccines: An update for gyne-cologists.Cli Obstet Gynecol 2008;51(3):527-532.

Garland SM and Smith JS.Human papillomavirus vaccines: Current Status and future prospects Drug 2010; 70(9):1079-1098.

Villa LL, Costa RL, Petta CA, et al.High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus like particle vaccine through 5-years of fol-low-up.Br. J Cancer 2006 Dec 4;95(11): 1459-1466.

Mc Cormack PL and Joura EA.Quadrivalent human papilloma-virus (Types 6,11,16,18) recombinant vaccine: A review of its use in the prevention of pre malignant genital lesions, genital cancer and genital warts in women.Drug 2010; 70(18): 2449-2474.

Einstein MH, Baron M; Levin MJ et al.Comparison of the immu-nogenicity and safety of CervarixTM and GardasilTM human pap-illomavirus (HPV) cervical vaccine in healthy women aged 18-45 years.Hum Vaccin2009 Oct;5(10): 705-719.

Rowhani-Rahbar A, Mao C, Hughes JP et al.Long-term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.Vaccine 2009 Sept 18;27(41): 5612-5619.

European Medicines Agency: Gardasil (Human papillomavirus vaccine [type 6, 11, 16, 18] recombinant absorbed): Summary of product characteristics (online).Available from URL:(http://www.ema.europa.Eu/humandocs/Humans/EPAR/gardasil/gardasil.htm).

Downloads

Published

2014-06-30

How to Cite

1.
Ambwani S, Prakash P, Surana S, Bhansali S. Human Papillomavirus Vaccine: A New Opportunity for The Treatment of Human Papillomavirus Infections. Natl J Community Med [Internet]. 2014 Jun. 30 [cited 2024 Dec. 3];5(02):259-60. Available from: https://njcmindia.com/index.php/file/article/view/1381

Issue

Vol. 5 No. 02 (2014)

Section

Perspective

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.